Tevogen (TVGN) EBT (2023 - 2026)
Tevogen Bio Holdings' (TVGN) quarterly EBT came in at -$5.4 million in Q1 2026, up 47.97% YoY from -$3.6 million in Q1 2025, and up 77.03% on a QoQ basis from -$23.5 million in Q4 2025.
Tevogen (TVGN) EBT (2023 - 2026) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 4 years of EBT data on file, last reported at -$5.4 million in Q1 2026.
- Quarterly EBT rose 47.97% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.1 million (down 13.39% YoY) and the FY2025 annual result came in at -$45.0 million, up 17.57% from the prior year.
- EBT grew to -$5.4 million in Q1 2026, from -$23.5 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$2.2 million in Q2 2023 to a low of -$29.7 million in Q1 2024.
- A 4-year average of -$8.8 million and a median of -$5.7 million in 2025 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT sank 1035.45% — and 2025, when it jumped 65.02%.
- Tracing TVGN's EBT over 4 years: stood at -$2.3 million in 2023, then sank by 341.47% to -$10.3 million in 2024, then plunged by 128.86% to -$23.5 million in 2025, then soared by 77.03% to -$5.4 million in 2026.
- The last three EBT figures came in at -$5.4 million (Q1 2026), -$23.5 million (Q4 2025), and -$5.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 81.49 Mn |
| 10 | Tevogen | 25.39 Mn | 25.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.40 Mn |
| Dec 31, 2025 | -23.51 Mn |
| Sep 30, 2025 | -5.73 Mn |
| Jun 30, 2025 | -5.44 Mn |
| Mar 31, 2025 | -10.38 Mn |
| Dec 31, 2024 | -10.27 Mn |
| Sep 30, 2024 | -6.10 Mn |
| Jun 30, 2024 | -8.60 Mn |
| Mar 31, 2024 | -29.67 Mn |
| Dec 31, 2023 | -2.33 Mn |
| Sep 30, 2023 | -2.62 Mn |
| Jun 30, 2023 | -2.18 Mn |
| Mar 31, 2023 | -2.61 Mn |